Skip to main content

Cardiol Therapeutics Inc.

corporate_fare Company Profile

Cardiol Therapeutics Inc.

CRDL·NASDAQ·Life Sciences·CIK 0001702123

Cardiol Therapeutics Inc. is a clinical-stage life sciences company that develops anti-fibrotic and anti-inflammatory therapies for heart diseases. The company's main product candidate is CardiolRx, which is currently in a Phase III multi-national, randomized, double-blind, and placebo-controlled study. This study is evaluating the effectiveness and safety of CardiolRx for treating acute myocarditis and recurrent pericarditis. Additionally, Cardiol Therapeutics Inc. is developing CRD-38, a new formulation of cannabidiol designed for subcutaneous administration to treat heart failure. The company was incorporated in 2017 and its headquarters are located in Oakville, Canada.

Cardiol Therapeutics Inc. (NASDAQ:CRDL) is a publicly traded company in the Life Sciences sector. Wiseek monitors CRDL SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Cardiol Therapeutics Reports Q1 2026 Results, $27.7M Cash, and Extends Runway into Q4 2027
  • Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in Journal of American Heart Association
  • Cardiol Therapeutics Expands Phase III MAVERIC Trial Network, Reaches 75% Patient Enrollment
  • Cardiol Therapeutics Secures Over $30M in Recent Financings, Advances Clinical Pipeline, and Appoints Key Board Member
  • Cardiol Therapeutics Publishes Positive Phase II ARCHER Study Results in ESC Heart Failure

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$33.82M
Diluted EPS
-$0.39
Op. Cash Flow
-$23.85M
Free Cash Flow
-$23.88M
Operating Income
-$34.32M
Cash & Equivalents
$21.42M
Debt / Equity
0.00×
Source: 40-F · filed 2026-03-31 · accession 0001104659-26-037844

Insider Transactions

CRDL files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with C →
$1.07 +0.01% today
52-week range · as of 2026-05-11 $0.88 – $1.71
Market cap
$122.19M
Volume
258.5K (0.7× avg)
3-mo avg 378.7K
Live data · 2026-06-19 08:42 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CRDL - Latest Insights

CRDL
May 11, 2026, 5:27 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.35
Real-time Price: $1.07 info
Change: -$0.280 (-21%) info
Market Cap: $122.189M info
CRDL
May 07, 2026, 7:37 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.37
Real-time Price: $1.07 info
Change: -$0.300 (-22%) info
Market Cap: $122.189M info
CRDL
Apr 28, 2026, 7:50 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.46
Real-time Price: $1.07 info
Change: -$0.390 (-27%) info
Market Cap: $122.189M info
CRDL
Mar 31, 2026, 4:47 PM EDT
Filing Type: 40-F
Importance Score:
8
Price at Filing: $1.24
Real-time Price: $1.07 info
Change: -$0.170 (-14%) info
Market Cap: $122.189M info
CRDL
Feb 10, 2026, 7:32 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.03
Real-time Price: $1.07 info
Change: +$0.040 (+4%) info
Market Cap: $122.189M info
CRDL
Feb 02, 2026, 4:01 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.9607
Real-time Price: $1.07 info
Change: +$0.1093 (+11%) info
Market Cap: $122.189M info
CRDL
Jan 23, 2026, 9:26 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.03
Real-time Price: $1.07 info
Change: +$0.040 (+4%) info
Market Cap: $122.189M info
CRDL
Jan 16, 2026, 8:57 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $1.07 info
Change: +$0.010 (+0.94%) info
Market Cap: $122.189M info
CRDL
Jan 13, 2026, 7:30 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.9792
Real-time Price: $1.07 info
Change: +$0.0908 (+9%) info
Market Cap: $122.189M info